Intravenous autologous bone marrow mononuclear cells for ischemic stroke

Keyphrases

• Ischemic Stroke 100%
• Bone Marrow Mononuclear Cells 100%
• Autologous Cells 100%
• Bone Marrow 66%
• Mononuclear Cells 66%
• Cell Infusion 66%
• Bone Marrow Harvest 66%
• Cell Therapy 33%
• Middle Cerebral Artery 33%
• Neurological Deficit 33%
• Pulmonary Embolism 33%
• Adverse Events 33%
• Iliac Crest 33%
• Infarct Expansion 33%
• Reperfusion 33%
• Stroke Patients 33%
• Aged 80 Years and over 33%
• National Institutes of Health Stroke Scale (NIHSS) 33%
• Modified Rankin Scale 33%
• Acute Stroke 33%
• Severe Adverse Events 33%
• Bone Marrow Aspiration 33%
• Re-administration 33%
• Animal Model of Stroke 33%
• Barthel Index 33%
• Good Manufacturing Practice 33%
• Hemicraniectomy 33%
• Crest Cell 33%

Medicine and Dentistry

• Brain Ischemia 100%
• Mononuclear Cell 100%
• Apoplexy 83%
• Infusion 66%
• Adverse Event 33%
• Pulmonary Embolism 16%
• Prospective Study 16%
• Infarction 16%
• Middle Cerebral Artery 16%
• Iliac Crest 16%
• Cell Therapy 16%
• Hexachlorophene 16%
• National Institutes of Health Stroke Scale 16%
• Modified Rankin Scale 16%
• Bone Marrow Biopsy 16%
• Barthel Index 16%

Neuroscience

• Brain Ischemia 100%
• Cerebrovascular Accident 100%
• Middle Cerebral Artery 16%
• Cell Therapy 16%
• Pulmonary Embolism 16%
• Artificial Neural Network 16%